Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Among authors: klamroth r. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY).
Jiménez-Yuste V, Peyvandi F, Klamroth R, Castaman G, Shanmukhaiah C, Rangarajan S, García Chavez J, Martinez R, Kenet G, Alzahrani H, Robson S, Schmitt C, Kiialainen A, Meier O, Ozelo M. Jiménez-Yuste V, et al. Among authors: klamroth r. Res Pract Thromb Haemost. 2022 Nov 14;6(8):e12837. doi: 10.1002/rth2.12837. eCollection 2022 Nov. Res Pract Thromb Haemost. 2022. PMID: 36397934 Free PMC article.
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.
Pollmann H, Externest D, Ganser A, Eifrig B, Kreuz W, Lenk H, Pabinger I, Schramm W, Schwarz TF, Zimmermann R, Zavazava N, Oldenburg J, Klamroth R. Pollmann H, et al. Among authors: klamroth r. Haemophilia. 2007 Mar;13(2):131-43. doi: 10.1111/j.1365-2516.2006.01416.x. Haemophilia. 2007. PMID: 17286765
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia.
Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP, Scharrer I, Schramm W, Gorina E; Members of the HAEMO-QoL-A Steering Committee. Rentz A, et al. Among authors: klamroth r. Haemophilia. 2008 Sep;14(5):1023-34. doi: 10.1111/j.1365-2516.2008.01812.x. Epub 2008 Jul 28. Haemophilia. 2008. PMID: 18665853
Challenges and controversies in haemophilia care in adulthood.
Dolan G, Hermans C, Klamroth R, Madhok R, Schutgens RE, Spengler U. Dolan G, et al. Among authors: klamroth r. Haemophilia. 2009 Jan;15 Suppl 1:20-7. doi: 10.1111/j.1365-2516.2008.01949.x. Haemophilia. 2009. PMID: 19125937 Review.
European curriculum for thrombosis and haemostasis.
Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA; Interdisciplinary Working Group IDWG. Astermark J, et al. Among authors: klamroth r. Haemophilia. 2009 Jan;15(1):337-44. doi: 10.1111/j.1365-2516.2008.01836.x. Haemophilia. 2009. PMID: 19149857 No abstract available.
202 results